Stock Research for CBPO

CBPO

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CBPO Stock Chart & Research Data

The CBPO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CBPO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CBPO Due diligence Resources & Stock Charts

The CBPO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CBPO Detailed Price Forecast - CNN Money CNN View CBPO Detailed Summary - Google Finance
Yahoo View CBPO Detailed Summary - Yahoo! Finance Zacks View CBPO Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CBPO Trends & Analysis - Trade-Ideas Barrons View CBPO Major Holders - Barrons
NASDAQ View CBPO Call Transcripts - NASDAQ Seeking View CBPO Breaking News & Analysis - Seeking Alpha
Spotlight View CBPO Annual Report - CompanySpotlight.com OTC Report View CBPO OTC Short Report - OTCShortReport.com
TradeKing View CBPO Fundamentals - TradeKing Charts View CBPO SEC Filings - Bar Chart
WSJ View Historical Prices for CBPO - The WSJ Morningstar View Performance/Total Return for CBPO - Morningstar
MarketWatch View the Analyst Estimates for CBPO - MarketWatch CNBC View the Earnings History for CBPO - CNBC
StockMarketWatch View the CBPO Earnings - StockMarketWatch MacroAxis View CBPO Buy or Sell Recommendations - MacroAxis
Bullish View the CBPO Bullish Patterns - American Bulls Short Pains View CBPO Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CBPO Stock Mentions - StockTwits PennyStocks View CBPO Stock Mentions - PennyStockTweets
Twitter View CBPO Stock Mentions - Twitter Invest Hub View CBPO Investment Forum News - Investor Hub
Yahoo View CBPO Stock Mentions - Yahoo! Message Board Seeking Alpha View CBPO Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for CBPO - SECform4.com Insider Cow View Insider Transactions for CBPO - Insider Cow
CNBC View CBPO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CBPO - OTC Markets
Yahoo View Insider Transactions for CBPO - Yahoo! Finance NASDAQ View Institutional Holdings for CBPO - NASDAQ


Stock Charts

FinViz View CBPO Stock Insight & Charts - FinViz.com StockCharts View CBPO Investment Charts - StockCharts.com
BarChart View CBPO Stock Overview & Charts - BarChart Trading View View CBPO User Generated Charts - Trading View


Latest Financial News for CBPO

China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant
Posted on Monday June 11, 2018

BEIJING, June 11, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that Shandong Taibang Biological Products Co. Ltd., the Company's majority-owned subsidiary, recently obtained approval from the China Food and Drug Administration (the "CFDA") to begin human clinical trials on its Human Fibrin Sealant ("Fibrin Sealant") product. Fibrin Sealant is intended to be used as an adjunct to hemostasis on patients undergoing surgery in case traditional surgical techniques such as sutures, ligatures, and cauteries are ineffective or impractical.


Analysis: Positioning to Benefit within China Biologic Products, Merus N.V, Adient, G1 Therapeutics, Westport Fuel, and AppFolio — Research Highlights Growth, Revenue, and Consolidated Results
Posted on Wednesday June 06, 2018

NEW YORK, June 06, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of China ...


Was China Biologic Products Holdings Inc’s (NASDAQ:CBPO) Earnings Decline Part Of A Broader Industry Downturn?
Posted on Thursday May 31, 2018

Assessing China Biologic Products Holdings Inc’s (NASDAQ:CBPO) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple senseRead More...


Blog Exposure - Portola Pharma Receives Approval from FDA for Its Lead Candidate
Posted on Tuesday May 08, 2018

LONDON, UK / ACCESSWIRE / May 08, 2018 / If you want access to our free research report on Portola Pharma, Inc. (NASDAQ: PTLA), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=PTLA as the Company's latest news hit the wire. On May 03, 2018, the Company announced that the US Food and Drug Administration (FDA) has approved its lead candidate, Andexxa®, the first and only antidote indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. Active-Investors.com is currently working on the research report for China Biologic Products Holdings, Inc. (NASDAQ: CBPO), which also belongs to the Healthcare sector as the Company Portola Pharma.


Enter a stock symbol to view the stock details.